NCT06376162
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06376162 |
| Title | Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | LLS PedAL Initiative, LLC |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA | NLD | FRA | ESP | CAN | AUT |
CKB BOOST